Sign In
Buy RYTM
$84.71
+0.360 (+0.427%)
At Close: Jun 03, 2026
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
11:55am, Thursday, 15'th Sep 2022 Benzinga
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.
Sonnet BioTherapeutics Holdi
Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
10:23am, Thursday, 15'th Sep 2022 Benzinga
U.S. stock futures traded higher this morning ahead of several economic reports. Here are some big stocks recording losses in today’s pre-market trading session.
IronNet, Inc. (NYSE: IRNT) shares d
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
09:21am, Thursday, 15'th Sep 2022 Benzinga
Gainers
AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.
Avenue Therapeutics,
Twilio, AMTD Digital And Other Big Gainers From Wednesday
06:47am, Thursday, 15'th Sep 2022 Benzinga
U.S. stocks closed mostly higher with the Nasdaq 100 gaining around 100 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
AMTD Digital Inc. (NYSE: HKD)
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
02:20am, Thursday, 15'th Sep 2022 GlobeNewswire Inc.
BOSTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
08:01pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
BOSTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
09:14am, Tuesday, 13'th Sep 2022 Benzinga
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
InMed Pharmaceuticals Inc. (NASDAQ: INM)
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
08:13am, Friday, 09'th Sep 2022 Benzinga
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to sharehol
Expert Ratings for Rhythm Pharmaceuticals
05:11pm, Thursday, 08'th Sep 2022 Benzinga
Rhythm Pharmaceuticals (NASDAQ:RYTM) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
0
4
0
0
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
04:15pm, Thursday, 08'th Sep 2022 Benzinga
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
Amylyx Pharmaceu
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
02:42pm, Thursday, 08'th Sep 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 73.8%
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
08:01pm, Wednesday, 07'th Sep 2022 GlobeNewswire Inc.
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families
3 Healthcare Stocks That Are Beating the Market
01:29pm, Sunday, 28'th Aug 2022 The Motley Fool
Here's why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.
3 Healthcare Stocks That Are Beating the Market
09:29am, Sunday, 28'th Aug 2022
Here's why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.
Annovis Bio (ANVS) Begins Dosing in Phase III Parkinson's Study
05:12pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Annovis Bio (ANVS) doses first patient in the phase III study evaluating buntanetap in early Parkinson's Disease. Stock surges.
